Milestone Pharmaceuticals Inc.
MIST· Nasdaq
MISTMilestone Pharmaceuticals Inc.
Filed Aug 13, 2019 · 10-Q · 44 days after period end · 0001104659-19-045420
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Net Income | -$13.66M | -$3.59M |
| EPS Diluted | -$1.04 | -$12.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 13, 2019 · 44 d after period end
